This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Cerebral microangiopathy panel [8 genes]
Cerebrovascular diseases represent a reasonable percentage of neurological consultations in adults, and genetic factors can be among the underlying etiological causes. On top of different risk factors of this nature, a series of diseases following a Mendelian pattern of inheritance have been described. Although their prevalence is low, establishing a diagnosis allows for a more specific clinical management and family counseling.
Among the conditions considered for the development of these panels is particularly relevant cerebral microangiopathy, in which we highlight the following phenotypes:
- CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, the NOTCH3 gene). CADASIL is a disease characterized by episodes of recurrent ischemic stroke that begin in adulthood and are associated with cognitive decline that leads to dementia, migraine with aura, psychiatric disorders, and diffuse white matter lesions and subcortical infarcts on neuroimaging, with typical involvement of anterior temporal lobes.
- CARASIL (cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy, the HTRA1 gene). CARASIL is characterized by deep white matter alterations of early onset. Affected individuals may present with gait abnormalities due to spasticity, stroke-like episodes, mood disturbances, pseudobulbar palsy, and cognitive decline beginning between the ages of 20 and 50.
We have also developed a specific panel for familial cavernomatosis and other monogenic diseases, such as familial hemiplegic migraine, and diseases that present an imaging pattern in cerebral angiography similar to Moyamoya disease.
Steps to follow
How to order
1. Download & fill out
Please cover as many fields as possible in both documents
2. Sample collection
Three sample types: saliva, peripheral blood or genomic DNA
3. Pack the sample
Please pack the sample in a way to prevent leakage
4. Send the sample & the request
Please schedule the delivery for Mon–Thur: 8am – 5pm
5. Result: the report
Via: Client Site HIC / Client Site Imegen / Certified email
Solicita información de
Cerebral microangiopathy panel
Turnaround time (TAT): 6 weeks
Ref. S-202008556
- COL4A1
- COL4A2
- CTC1
- CTSA
- GLA
- HTRA1
- NOTCH3
- TREX1
Priority Genes : Genes where there is sufficient evidence (clinical and functional) to consider them associated with the disease; they are included in the clinical practice guidelines.
Secondary Genes: Genes related to the disease, but with a lower level of evidence or that constitute sporadic cases.
* Candidate Genes: Not enough evidence in humans, but potentially associated with the disease.
- Ilinca A, Samuelsson S, Piccinelli P, et al. A stroke gene panel for whole-exome sequencing. Eur J Hum Genet. 2019 Feb;27(2):317-324. doi: 10.1038/s41431-018-0274-4.
- Mancuso M, Arnold M, Bersano A, et al. Monogenic cerebral small-vessel diseases: diagnosis and therapy. Consensus recommendations of the European Academy of Neurology. Eur J Neurol. 2020 Mar 20. doi: 10.1111/ene.14183.